Uridine metabolism in HIV-1-infected patients: effect of infection, of antiretroviral therapy and of HIV-1/ART-associated lipodystrophy syndrome.
<h4>Background</h4>Uridine has been advocated for the treatment of HIV-1/HAART-associated lipodystrophy (HALS), although its metabolism in HIV-1-infected patients is poorly understood.<h4>Methods</h4>Plasma uridine concentrations were measured in 35 controls and 221 HIV-1-inf...
Guardado en:
Autores principales: | Pere Domingo, Javier Torres-Torronteras, Virginia Pomar, Marta Giralt, Joan Carles Domingo, Maria Del Mar Gutierrez, José M Gallego-Escuredo, Maria Gracia Mateo, Pedro Cano-Soldado, Irene Fernandez, Marçal Pastor-Anglada, Francesc Vidal, Francesc Villarroya, Antoni Andreu, Ramon Marti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/22a61b1f92254da39add10ac81c125f9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association of thymidylate synthase polymorphisms with acute pancreatitis and/or peripheral neuropathy in HIV-infected patients on stavudine-based therapy.
por: Pere Domingo, et al.
Publicado: (2013) -
New and emerging agents in the management of lipodystrophy in HIV-infected patients
por: Eric Bonnet
Publicado: (2010) -
Lipodystrophy in HIV patients: its challenges and management approaches
por: Singhania R, et al.
Publicado: (2011) -
Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy
por: Bedimo R
Publicado: (2011) -
Excisional lipectomy versus liposuction in HIV-associated lipodystrophy
por: Natalie Barton, et al.
Publicado: (2021)